Syndax Pharmaceuticals PE Ratio 2015-2025 | SNDX

Current and historical p/e ratio for Syndax Pharmaceuticals (SNDX) from 2015 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Syndax Pharmaceuticals PE ratio as of December 04, 2025 is 0.00.
Syndax Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-12-04 19.74 0.00
2025-09-30 15.39 $-3.61 0.00
2025-06-30 9.37 $-3.89 0.00
2025-03-31 12.29 $-3.86 0.00
2024-12-31 13.22 $-3.73 0.00
2024-09-30 19.25 $-3.63 0.00
2024-06-30 20.53 $-3.38 0.00
2024-03-31 23.80 $-3.22 0.00
2023-12-31 21.61 $-2.96 0.00
2023-09-30 14.52 $-2.58 0.00
2023-06-30 20.93 $-2.43 0.00
2023-03-31 21.12 $-2.41 0.00
2022-12-31 25.45 $-2.45 0.00
2022-09-30 24.03 $-0.02 0.00
2022-06-30 19.24 $0.16 120.25
2022-03-31 17.38 $0.34 51.12
2021-12-31 21.89 $0.43 50.91
2021-09-30 19.11 $-1.82 0.00
2021-06-30 17.17 $-1.88 0.00
2021-03-31 22.36 $-1.86 0.00
2020-12-31 22.24 $-1.88 0.00
2020-09-30 14.76 $-1.88 0.00
2020-06-30 14.82 $-1.83 0.00
2020-03-31 10.97 $-1.88 0.00
2019-12-31 8.78 $-1.85 0.00
2019-09-30 7.47 $-2.11 0.00
2019-06-30 9.31 $-2.38 0.00
2019-03-31 5.25 $-2.65 0.00
2018-12-31 4.45 $-2.91 0.00
2018-09-30 8.08 $-3.01 0.00
2018-06-30 7.02 $-3.01 0.00
2018-03-31 14.23 $-2.97 0.00
2017-12-31 8.76 $-2.89 0.00
2017-09-30 11.70 $-2.68 0.00
2017-06-30 13.97 $-2.84 0.00
2017-03-31 13.72 $-2.61 0.00
2016-12-31 7.17 $-4.75 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.713B $0.024B
Syndax Pharmaceuticals, Inc. is a biopharmaceutical company which focused on the development and commercialization of entinostat, an epigenetic therapy for treatment-resistant cancers. The Company's product pipeline includes ENCORE 601, ENCORE 602, J1353, NCI-7870, NCI-9844, E2112, NCI-8871 and NCI-9253 which are in clinical trial stage. Syndax Pharmaceuticals, Inc. is based in WALTHAM, United States.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $281.765B 19.88
Amgen (AMGN) United States $186.002B 15.79
Gilead Sciences (GILD) United States $155.085B 15.26
Vertex Pharmaceuticals (VRTX) United States $117.505B 30.25
Bristol Myers Squibb (BMY) United States $103.742B 7.77
GSK (GSK) United Kingdom $99.429B 11.05
Regeneron Pharmaceuticals (REGN) United States $76.057B 19.73
Alnylam Pharmaceuticals (ALNY) United States $62.528B 2057.78
CSL (CSLLY) Australia $58.655B 0.00
Argenex SE (ARGX) Netherlands $56.754B 70.47
Insmed (INSM) United States $44.101B 0.00
Novozymes (NVZMY) Denmark $28.477B 0.00
Biogen (BIIB) United States $26.516B 10.80
Royalty Pharma (RPRX) United States $22.859B 8.76
BioNTech SE (BNTX) Germany $21.782B 0.00
Genmab (GNMSF) Denmark $20.751B 15.22
Genmab (GMAB) Denmark $20.351B 15.30
Incyte (INCY) United States $19.927B 19.08
Illumina (ILMN) United States $19.551B 29.35
Exact Sciences (EXAS) United States $19.184B 532.90
Revolution Medicines (RVMD) United States $15.019B 0.00
Roivant Sciences (ROIV) United Kingdom $14.397B 0.00
Guardant Health (GH) United States $13.355B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $12.549B 23.34
Ascendis Pharma (ASND) Denmark $12.370B 0.00
Exelixis (EXEL) United States $11.800B 18.89
Avidity Biosciences (RNA) United States $10.785B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.434B 18.92
QIAGEN (QGEN) Netherlands $10.408B 19.75
Jazz Pharmaceuticals (JAZZ) Ireland $10.154B 39.60
Bio-Techne Corp (TECH) United States $9.944B 37.10
Moderna (MRNA) United States $9.839B 0.00
Repligen (RGEN) United States $9.374B 100.31
Arrowhead Pharmaceuticals (ARWR) United States $8.838B 0.00
Abivax SA (ABVX) France $8.634B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.381B 30.14
Cytokinetics (CYTK) United States $7.906B 0.00
Nuvalent (NUVL) United States $7.772B 0.00
Halozyme Therapeutics (HALO) United States $7.604B 12.15
Axsome Therapeutics (AXSM) United States $7.451B 0.00
Merus (MRUS) Netherlands $7.290B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.983B 0.00
Cidara Therapeutics (CDTX) United States $6.947B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.433B 0.00
Krystal Biotech (KRYS) United States $6.306B 32.60
Vaxcyte (PCVX) United States $6.244B 0.00
PTC Therapeutics (PTCT) United States $6.083B 8.26
Cogent Biosciences (COGT) United States $5.575B 0.00
Zealand Pharma (ZLDPF) Denmark $5.480B 5.55
Protagonist Therapeutics (PTGX) United States $5.381B 138.82
CRISPR Therapeutics AG (CRSP) Switzerland $5.336B 0.00
Belite Bio (BLTE) United States $5.296B 0.00
Legend Biotech (LEGN) United States $5.125B 0.00
Apogee Therapeutics (APGE) United States $5.093B 0.00
TG Therapeutics (TGTX) United States $5.018B 11.37
Anbio Biotechnology (NNNN) Germany $4.967B 0.00
Alkermes (ALKS) Ireland $4.876B 14.34
Kymera Therapeutics (KYMR) United States $4.748B 0.00
ADMA Biologics Inc (ADMA) United States $4.693B 33.42
Praxis Precision Medicines (PRAX) United States $4.655B 0.00
Celcuity (CELC) United States $4.627B 0.00
Akero Therapeutics (AKRO) United States $4.502B 0.00
Scholar Rock Holding (SRRK) United States $4.438B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.378B 36.97
Arcellx (ACLX) United States $4.218B 0.00
Viking Therapeutics (VKTX) United States $4.003B 0.00
Immunovant (IMVT) United States $3.981B 0.00
GRAIL (GRAL) United States $3.945B 0.00
Ligand Pharmaceuticals (LGND) United States $3.799B 93.25
Arcutis Biotherapeutics (ARQT) United States $3.670B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.648B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.517B 0.00
Disc Medicine (IRON) United States $3.487B 0.00
Tarsus Pharmaceuticals (TARS) United States $3.476B 0.00
CG Oncology (CGON) United States $3.437B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.423B 0.00
Telix Pharmaceuticals (TLX) Australia $3.272B 0.00
Travere Therapeutics (TVTX) United States $3.118B 0.00
Mineralys Therapeutics (MLYS) United States $3.102B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $3.077B 90.20
Amicus Therapeutics (FOLD) United States $3.017B 244.50
IDEAYA Biosciences (IDYA) United States $3.010B 0.00
Viridian Therapeutics (VRDN) United States $2.987B 0.00
Liquidia (LQDA) United States $2.935B 0.00
Nuvation Bio (NUVB) United States $2.870B 0.00
Ascentage Pharma Group - (AAPG) China $2.831B 0.00
Denali Therapeutics (DNLI) United States $2.787B 0.00
Arcus Biosciences (RCUS) United States $2.767B 0.00
Beam Therapeutics (BEAM) United States $2.713B 0.00
Apellis Pharmaceuticals (APLS) United States $2.689B 68.55
Vera Therapeutics (VERA) United States $2.638B 0.00
Adaptive Biotechnologies (ADPT) United States $2.615B 0.00
Spyre Therapeutics (SYRE) United States $2.498B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.487B 0.00
Terns Pharmaceuticals (TERN) United States $2.476B 0.00
Edgewise Therapeutics (EWTX) United States $2.469B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.426B 0.00
Bavarian Nordic (BVNRY) Denmark $2.325B 6.31
Sarepta Therapeutics (SRPT) United States $2.289B 0.00
Jyong Biotech (MENS) Taiwan $2.224B 0.00
Zai Lab (ZLAB) China $2.211B 0.00
Mesoblast (MESO) Australia $2.172B 0.00
ImmunityBio (IBRX) United States $2.167B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.131B 11.64
Maze Therapeutics (MAZE) United States $1.996B 0.00
Zenas BioPharma (ZBIO) United States $1.968B 0.00
Zymeworks (ZYME) United States $1.962B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.914B 0.00
Twist Bioscience (TWST) United States $1.906B 0.00
Vericel (VCEL) United States $1.891B 155.79
Dianthus Therapeutics (DNTH) United States $1.885B 0.00
Olema Pharmaceuticals (OLMA) United States $1.871B 0.00
ANI Pharmaceuticals (ANIP) United States $1.858B 14.40
Celldex Therapeutics (CLDX) United States $1.848B 0.00
Sionna Therapeutics (SION) United States $1.837B 0.00
Structure Therapeutics (GPCR) United States $1.827B 0.00
Immunome (IMNM) United States $1.776B 0.00
Stoke Therapeutics (STOK) United States $1.768B 46.21
Trevi Therapeutics (TRVI) United States $1.757B 0.00
MannKind (MNKD) United States $1.717B 55.90
Agios Pharmaceuticals (AGIO) United States $1.603B 0.00
UniQure (QURE) Netherlands $1.587B 0.00
NeoGenomics (NEO) United States $1.568B 0.00
Certara (CERT) United States $1.542B 28.47
Pharvaris (PHVS) Netherlands $1.536B 0.00
MBX Biosciences (MBX) United States $1.524B 0.00
Atai Beckley N.V (ATAI) Netherlands $1.475B 0.00
Upstream Bio (UPB) United States $1.457B 0.00
Alvotech (ALVO) Luxembourg $1.399B 20.17
Fortrea Holdings (FTRE) United States $1.347B 28.59
Rapport Therapeutics (RAPP) United States $1.323B 0.00
NovoCure (NVCR) Jersey $1.323B 0.00
Nurix Therapeutics (NRIX) United States $1.294B 0.00
Tango Therapeutics (TNGX) United States $1.289B 0.00
Dynavax Technologies (DVAX) United States $1.288B 37.83
Precigen (PGEN) United States $1.263B 0.00
Immatics (IMTX) Germany $1.257B 0.00
Kodiak Sciences (KOD) United States $1.218B 0.00
AnaptysBio (ANAB) United States $1.212B 0.00
Inhibrx Biosciences (INBX) United States $1.207B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $1.202B 0.00
WAVE Life Sciences (WVE) Singapore $1.194B 0.00
Sana Biotechnology (SANA) United States $1.191B 0.00
Septerna (SEPN) United States $1.189B 0.00
Mind Medicine (MindMed) (MNMD) United States $1.176B 0.00
Tyra Biosciences (TYRA) United States $1.158B 0.00
CureVac (CVAC) Germany $1.158B 0.00
Castle Biosciences (CSTL) United States $1.150B 157.64
Urogen Pharma (URGN) United States $1.140B 0.00
Novavax (NVAX) United States $1.111B 2.83
Pharming Group (PHGUF) Netherlands $1.107B 165.00
Monte Rosa Therapeutics (GLUE) United States $1.098B 52.69
Palvella Therapeutics (PVLA) United States $1.088B 0.00
Pharming Group (PHAR) Netherlands $1.083B 0.00
Oric Pharmaceuticals (ORIC) United States $1.069B 0.00
Intellia Therapeutics (NTLA) United States $1.049B 0.00
AbCellera Biologics (ABCL) Canada $1.045B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.044B 0.00
Kura Oncology (KURA) United States $1.042B 0.00
Pacira BioSciences (PCRX) United States $1.041B 11.92
MiMedx (MDXG) United States $1.031B 18.32
Janux Therapeutics (JANX) United States $1.029B 0.00
Nanobiotix S.A - (NBTX) France $1.008B 0.00
Bicara Therapeutics (BCAX) United States $0.995B 0.00
Oculis Holding AG (OCS) Switzerland $0.995B 0.00
Biohaven (BHVN) United States $0.965B 0.00
ArriVent BioPharma (AVBP) United States $0.945B 0.00
Compass Therapeutics (CMPX) United States $0.939B 0.00
Erasca (ERAS) United States $0.933B 0.00
YD Bio (YDES) $0.914B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.896B 0.00
Rapt Therapeutics (RAPT) United States $0.889B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $0.885B 0.00
Rezolute (RZLT) United States $0.878B 0.00
Iovance Biotherapeutics (IOVA) United States $0.877B 0.00
LENZ Therapeutics (LENZ) United States $0.876B 0.00
Vir Biotechnology (VIR) United States $0.872B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $0.857B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.853B 0.00
Arbutus Biopharma (ABUS) United States $0.852B 0.00
Alumis (ALMS) United States $0.818B 0.00
Arvinas (ARVN) United States $0.814B 0.00
CorMedix Inc (CRMD) United States $0.813B 7.53
Geron (GERN) United States $0.811B 0.00
Replimune (REPL) United States $0.810B 0.00
Gossamer Bio (GOSS) United States $0.792B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.781B 0.00
GH Research (GHRS) Ireland $0.748B 0.00
Astria Therapeutics (ATXS) United States $0.747B 0.00
Gyre Therapeutics (GYRE) United States $0.736B 95.50
BGM Group (BGM) China $0.736B 0.00
MapLight Therapeutics (MPLT) United States $0.701B 0.00
Cytek Biosciences (CTKB) United States $0.685B 0.00
Myriad Genetics (MYGN) United States $0.683B 0.00
CytomX Therapeutics (CTMX) United States $0.678B 10.00
Verastem (VSTM) United States $0.672B 0.00
MeiraGTx Holdings (MGTX) United States $0.654B 0.00
REGENXBIO (RGNX) United States $0.652B 0.00
Prime Medicine (PRME) United States $0.652B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Evommune (EVMN) $0.638B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.630B 0.00
Cullinan Therapeutics (CGEM) United States $0.620B 0.00
Emergent Biosolutions (EBS) United States $0.609B 5.86
Prothena (PRTA) Ireland $0.601B 0.00
Bright Minds Biosciences (DRUG) United States $0.577B 0.00
Inventiva S.A (IVA) France $0.576B 0.00
Ventyx Biosciences (VTYX) United States $0.559B 0.00
Design Therapeutics (DSGN) United States $0.557B 0.00
Jade Biosciences (JBIO) United States $0.552B 0.00
Keros Therapeutics (KROS) United States $0.551B 11.75
Ginkgo Bioworks Holdings (DNA) United States $0.546B 0.00
Niagen Bioscience (NAGE) United States $0.521B 40.81
Invivyd (IVVD) United States $0.520B 0.00
EnGene Holdings (ENGN) Canada $0.517B 0.00
Monopar Therapeutics (MNPR) United States $0.516B 0.00
Annexon (ANNX) United States $0.512B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.509B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.495B 0.00
Absci (ABSI) United States $0.495B 0.00
Fulcrum Therapeutics (FULC) United States $0.490B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.489B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.475B 0.00
DBV Technologies S.A (DBVT) France $0.467B 0.00
NovaBridge Biosciences (NBP) United States $0.444B 0.00
DiaMedica Therapeutics (DMAC) United States $0.443B 0.00
Eton Pharmaceuticals (ETON) United States $0.442B 0.00
Immuneering (IMRX) United States $0.435B 0.00
Benitec Biopharma (BNTC) United States $0.426B 0.00
Alto Neuroscience (ANRO) United States $0.416B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.411B 0.00
Anavex Life Sciences (AVXL) United States $0.408B 0.00
Kamada (KMDA) Israel $0.408B 19.69
PureTech Health (PRTC) United States $0.406B 0.00
Solid Biosciences (SLDB) United States $0.404B 0.00
Aura Biosciences (AURA) United States $0.400B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.394B 0.00
Entrada Therapeutics (TRDA) United States $0.385B 0.00
XOMA Royalty (XOMA) United States $0.384B 0.00
Neumora Therapeutics (NMRA) United States $0.379B 0.00
Tectonic Therapeutic (TECX) United States $0.378B 0.00
Ocugen (OCGN) United States $0.378B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.361B 0.00
PepGen (PEPG) United States $0.361B 0.00
Northwest Biotherapeutics (NWBO) United States $0.356B 0.00
Allogene Therapeutics (ALLO) United States $0.342B 0.00
Amarin (AMRN) Ireland $0.339B 0.00
BioAge Labs (BIOA) United States $0.331B 0.00
Contineum Therapeutics (CTNM) United States $0.325B 0.00
Kyverna Therapeutics (KYTX) United States $0.314B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.312B 0.00
Neurogene (NGNE) United States $0.312B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.311B 0.00
GENFIT S.A (GNFTY) France $0.292B 0.00
Lifecore Biomedical (LFCR) United States $0.286B 0.00
AC Immune (ACIU) Switzerland $0.286B 0.00
X4 Pharmaceuticals (XFOR) United States $0.284B 0.00
Candel Therapeutics (CADL) United States $0.276B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.274B 0.00
C4 Therapeutics (CCCC) United States $0.272B 0.00
Nautilus Biotechnology (NAUT) United States $0.263B 0.00
Puma Biotechnology (PBYI) United States $0.262B 7.01
Aardvark Therapeutics (AARD) United States $0.260B 0.00
Adherex Technologies (FENC) United States $0.258B 0.00
Alpha Teknova (TKNO) United States $0.257B 0.00
Abeona Therapeutics (ABEO) United States $0.256B 4.19
Palisade Bio (PALI) United States $0.252B 0.00
Foghorn Therapeutics (FHTX) United States $0.251B 0.00
Prima BioMed (IMMP) Australia $0.250B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.242B 0.00
Humacyte (HUMA) United States $0.242B 0.00
Atea Pharmaceuticals (AVIR) United States $0.241B 0.00
Cabaletta Bio (CABA) United States $0.241B 0.00
Zura Bio (ZURA) United States $0.239B 0.00
Voyager Therapeutics (VYGR) United States $0.235B 0.00
Editas Medicine (EDIT) United States $0.231B 0.00
Forte Biosciences (FBRX) United States $0.229B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.223B 0.00
Tenaya Therapeutics (TNYA) United States $0.221B 0.00
SELLAS Life Sciences (SLS) United States $0.219B 0.00
Adocia (ADOCY) France $0.216B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.214B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.211B 0.00
Sagimet Biosciences (SGMT) United States $0.210B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.197B 0.00
Rani Therapeutics Holdings (RANI) United States $0.197B 0.00
Quince Therapeutics (QNCX) United States $0.196B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.187B 0.00
Crescent Biopharma (CBIO) United States $0.186B 0.00
Molecular Partners AG (MOLN) Switzerland $0.180B 0.00
Genelux (GNLX) United States $0.177B 0.00
SAB Biotherapeutics (SABS) United States $0.176B 0.00
Innate Pharma S.A (IPHA) France $0.175B 0.00
Caribou Biosciences (CRBU) United States $0.174B 0.00
Cartesian Therapeutics (RNAC) United States $0.173B 0.00
Actuate Therapeutics (ACTU) United States $0.173B 0.00
Sangamo Therapeutics (SGMO) United States $0.168B 0.00
Shattuck Labs (STTK) United States $0.165B 0.00
Nuvectis Pharma (NVCT) United States $0.163B 0.00
MaxCyte (MXCT) United States $0.162B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.160B 0.00
Cognition Therapeutics (CGTX) United States $0.159B 0.00
Seres Therapeutics (MCRB) United States $0.158B 0.00
Black Diamond Therapeutics (BDTX) United States $0.153B 7.47
Codexis (CDXS) United States $0.153B 0.00
CAMP4 Therapeutics (CAMP) United States $0.152B 0.00
Scilex Holding (SCLX) United States $0.151B 0.00
Connect Biopharma Holdings (CNTB) United States $0.148B 0.00
Coherus Oncology (CHRS) United States $0.147B 0.00
VistaGen Therapeutics (VTGN) United States $0.147B 0.00
Opus Genetics (IRD) United States $0.144B 0.00
Cardiff Oncology (CRDF) United States $0.143B 0.00
Agenus (AGEN) United States $0.142B 0.00
Elicio Therapeutics (ELTX) United States $0.141B 0.00
Compugen (CGEN) Israel $0.140B 0.00
Immix Biopharma (IMMX) United States $0.139B 0.00
Mersana Therapeutics (MRSN) United States $0.139B 0.00
Anika Therapeutics (ANIK) United States $0.137B 0.00
Inovio Pharmaceuticals (INO) United States $0.135B 0.00
Coya Therapeutics (COYA) United States $0.129B 0.00
Spero Therapeutics (SPRO) United States $0.128B 0.00
Nkarta (NKTX) United States $0.126B 0.00
Alpha Cognition (ACOG) Canada $0.126B 0.00
EXoZymes (EXOZ) United States $0.126B 0.00
Fate Therapeutics (FATE) United States $0.125B 0.00
Alector (ALEC) United States $0.124B 0.00
Annovis Bio (ANVS) United States $0.123B 0.00
Turn Therapeutics (TTRX) United States $0.120B 0.00
Climb Bio (CLYM) United States $0.119B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.117B 0.00
Greenwich LifeSciences (GLSI) United States $0.117B 0.00
Ovid Therapeutics (OVID) United States $0.113B 0.00
BioHarvest Sciences (BHST) Canada $0.107B 0.00
Whitehawk Therapeutics (WHWK) United States $0.106B 0.00
Seer (SEER) United States $0.105B 0.00
Kalaris Therapeutics (KLRS) United States $0.104B 0.00
Citius Oncology (CTOR) United States $0.102B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.102B 0.00
VTv Therapeutics (VTVT) United States $0.102B 0.00
Starpharma Holdings (SPHRY) Australia $0.100B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.100B 0.00
Chrome Holding (MEHCQ) United States $0.099B 0.00
TuHURA Biosciences (HURA) United States $0.098B 0.00
Adagene (ADAG) China $0.097B 0.00
Spruce Biosciences (SPRB) United States $0.097B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.096B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.095B 0.00
Pliant Therapeutics (PLRX) United States $0.095B 0.00
Entera Bio (ENTX) Israel $0.094B 0.00
Repare Therapeutics (RPTX) Canada $0.093B 0.00
Adverum Biotechnologies (ADVM) United States $0.092B 0.00
Oncolytics Biotech (ONCY) Canada $0.091B 0.00
Atara Biotherapeutics (ATRA) United States $0.090B 5.76
Vor Biopharma (VOR) $0.089B 0.00
Artiva Biotherapeutics (ARTV) United States $0.088B 0.00
Oncobiologics (OTLK) United States $0.088B 0.00
Tharimmune (THAR) United States $0.087B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.085B 0.00
Tevogen Bio Holdings (TVGN) United States $0.085B 0.00
Fortress Biotech (FBIO) United States $0.083B 0.00
Adicet Bio (ACET) United States $0.082B 0.00
XBiotech (XBIT) United States $0.079B 0.00
Immunic (IMUX) United States $0.078B 0.00
Instil Bio (TIL) United States $0.078B 0.00
BeyondSpring (BYSI) United States $0.077B 0.00
CervoMed (CRVO) United States $0.077B 0.00
ATyr Pharma (ATYR) United States $0.076B 0.00
Clene (CLNN) United States $0.075B 0.00
Biomea Fusion (BMEA) United States $0.074B 0.00
ImageneBio (IMA) United States $0.074B 0.00
Sutro Biopharma (STRO) United States $0.074B 0.00
BioStem Technologies (BSEM) $0.073B 5.11
ALX Oncology Holdings (ALXO) United States $0.072B 0.00
InflaRx (IFRX) Germany $0.068B 0.00
CalciMedica (CALC) United States $0.068B 0.00
Precision BioSciences (DTIL) United States $0.067B 0.00
Estrella Immunopharma (ESLA) United States $0.065B 0.00
OKYO Pharma (OKYO) $0.065B 0.00
ABVC BioPharma (ABVC) United States $0.062B 0.00
Aligos Therapeutics (ALGS) United States $0.061B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.060B 0.00
TScan Therapeutics (TCRX) United States $0.058B 0.00
Senti Biosciences (SNTI) United States $0.058B 0.00
Tenax Therapeutics (TENX) United States $0.057B 0.00
Celularity (CELU) United States $0.057B 0.00
Equillium (EQ) United States $0.053B 0.00
Femasys (FEMY) United States $0.052B 0.00
MiNK Therapeutics (INKT) United States $0.051B 0.00
Adlai Nortye (ANL) Cayman Islands $0.050B 0.00
Grace Therapeutics (GRCE) United States $0.049B 0.00
BioAtla (BCAB) United States $0.049B 0.00
INmune Bio (INMB) United States $0.047B 0.00
TELA Bio (TELA) United States $0.046B 0.00
Jasper Therapeutics (JSPR) United States $0.046B 0.00
IO Biotech (IOBT) Denmark $0.046B 0.00
Kezar Life Sciences (KZR) United States $0.046B 0.00
Werewolf Therapeutics (HOWL) United States $0.045B 0.00
Cue Biopharma (CUE) United States $0.044B 0.00
Q32 Bio (QTTB) United States $0.044B 0.00
BioXcel Therapeutics (BTAI) United States $0.042B 0.00
PDS Biotechnology (PDSB) United States $0.042B 0.00
Radiopharm Theranostics - (RADX) Australia $0.042B 0.00
Lantern Pharma (LTRN) United States $0.040B 0.00
Skye Bioscience (SKYE) United States $0.039B 0.00
Tvardi Therapeutics (TVRD) United States $0.039B 0.00
Quantum Biopharma (QNTM) Canada $0.038B 0.00
Medicus Pharma (MDCX) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
Rein Therapeutics (RNTX) United States $0.036B 0.00
Genenta Science S.p.A (GNTA) Italy $0.036B 0.00
OnKure Therapeutics (OKUR) United States $0.036B 0.00
Exicure (XCUR) United States $0.035B 0.00
Generation Bio (GBIO) United States $0.035B 0.00
Dyadic (DYAI) United States $0.034B 0.00
RenovoRx (RNXT) United States $0.033B 0.00
NextCure (NXTC) United States $0.032B 0.00
Pluri (PLUR) Israel $0.032B 0.00
Alterity Therapeutics - (ATHE) Australia $0.031B 0.00
Applied Therapeutics (APLT) United States $0.030B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.030B 0.00
Galecto (GLTO) Denmark $0.029B 0.00
AN2 Therapeutics (ANTX) United States $0.029B 0.00
Hyperion DeFi (HYPD) United States $0.029B 0.00
Rallybio (RLYB) United States $0.028B 0.00
Elutia (ELUT) United States $0.028B 0.00
Passage Bio (PASG) United States $0.027B 0.00
Cingulate (CING) United States $0.027B 0.00
Black Titan (BTTC) United States $0.026B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.026B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
Lexaria Bioscience (LEXX) Canada $0.025B 0.00
Intensity Therapeutics (INTS) United States $0.025B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.024B 0.00
BRIACELL THERAP (BCTX) Canada $0.024B 0.00
IBio (IBIO) United States $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Neuphoria Therapeutics (NEUP) United States $0.023B 0.00
Novogen (KZIA) Australia $0.022B 0.00
Aytu BioPharma (AYTU) United States $0.022B 0.00
Hoth Therapeutics (HOTH) United States $0.019B 0.00
Cadrenal Therapeutics (CVKD) United States $0.018B 0.00
Bionano Genomics (BNGO) United States $0.018B 0.00
Allarity Therapeutics (ALLR) United States $0.017B 0.00
Lisata Therapeutics (LSTA) United States $0.017B 0.00
Curis (CRIS) United States $0.016B 0.00
NewcelX (NCEL) Switzerland $0.016B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
Soligenix (SNGX) United States $0.016B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
Moleculin Biotech (MBRX) United States $0.015B 0.00
Chemomab Therapeutics (CMMB) Israel $0.015B 0.00
Apollomics (APLM) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
Athira Pharma (ATHA) United States $0.015B 0.00
BioCardia (BCDA) United States $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.014B 0.00
Dogwood Therapeutics (DWTX) United States $0.014B 0.00
FibroBiologics (FBLG) United States $0.014B 0.00
Longeveron (LGVN) United States $0.014B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.013B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.012B 0.00
Imunon (IMNN) United States $0.012B 0.00
Edesa Biotech (EDSA) Canada $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.011B 0.00
Gelteq (GELS) Australia $0.010B 0.00
Bolt Biotherapeutics (BOLT) United States $0.010B 0.00
Purple Biotech (PPBT) Israel $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.010B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Beyond Air (XAIR) United States $0.009B 0.00
Pasithea Therapeutics (KTTA) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Advanced Biomed (ADVB) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Polyrizon (PLRZ) Israel $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Aprea Therapeutics (APRE) United States $0.007B 0.00
KALA BIO (KALA) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
GRI Bio (GRI) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Revelation Biosciences (REVB) United States $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Alps Group (ALPS) United States $0.004B 3.24
Scinai Immunotherapeutics (SCNI) Israel $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00